Next Wave Ltd was established in late 80’s to develop the Physioacoustic Sound Wave Therapy devices for healthcare and well-being purposes

The Physioacoustic chair and mattress are listed by the FDA in the US for relaxing muscles, reducing stress and pain where applied, increasing blood and lymphatic circulation. The products are suitable for all age groups and especially they have shown good results with the elderly users and patients. The Physioacoustic method has three important sound parameters, which are: pulsation, scanning and direction. The Physioacoustic electronic device is certified by the BSI in the UK.

Studies:

1. Effects of a low-frequency sound wave therapy program on functional capacity, blood circulation, and bone metabolism in frail old men and women.
Published in Clinical Rehabilitation, 2008
2. Short-term effects of vibration therapy on motor impairments in Parkinson’s disease

NeuroRehabilitation 25 (2009) 297–306 297 DOI 10.3233/NRE-2009-0528 IOS Press

3. Sound Stimulation in Patients With Alzheimer’s Disease

Will be published soon

4. Short-term effects of vibration therapy in Parkinson’s disease

Ready to be submitted to a medical publication

5. Effectiveness of Physio Acoustic Sound (PAS) therapy in demented nursing home residents with nocturnal restlessness: study protocol for a randomized controlled trial

Ready soon to be submitted to a medical publication

6. A Physioacoustic chair trial which was done at residential aged care setting in Gold Coast Australia and carried out during April – May 2011
The trial of the chair was aimed at assessing impact on:
• agitation/ restlessness in the dementia residents
• level of pain
• level of mobility

Report was made by the senior physiotherapist who conducted the trial with the assistance of their care staff in June 27th, 2011

Web: www.nextwaveworldwide.com

Next Wave brochure 2014

33 10 copy